FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 61 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10 | -23.1% | 1,914 | +4.0% | 0.00% | – |
Q2 2023 | $13 | -84.7% | 1,841 | -86.5% | 0.00% | – |
Q1 2023 | $85 | -2.3% | 13,686 | 0.0% | 0.00% | – |
Q4 2022 | $87 | -99.9% | 13,686 | +0.0% | 0.00% | – |
Q3 2022 | $117,000 | -37.1% | 13,683 | +0.3% | 0.00% | – |
Q2 2022 | $186,000 | -10.6% | 13,641 | -0.2% | 0.00% | – |
Q1 2022 | $208,000 | -33.3% | 13,673 | +0.1% | 0.00% | – |
Q4 2021 | $312,000 | +63.4% | 13,655 | -0.3% | 0.00% | – |
Q3 2021 | $191,000 | +6.7% | 13,701 | -18.2% | 0.00% | – |
Q2 2021 | $179,000 | +231.5% | 16,758 | +308.7% | 0.00% | – |
Q1 2021 | $54,000 | -34.9% | 4,100 | 0.0% | 0.00% | – |
Q4 2020 | $83,000 | – | 4,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Capital LLC | 1,261,261 | $13,458,000 | 4.37% |
Birchview Capital, LP | 314,143 | $3,352,000 | 2.00% |
Flagship Pioneering Inc. | 12,674,120 | $135,233,000 | 1.73% |
Monashee Investment Management LLC | 530,581 | $5,661,000 | 0.68% |
Artal Group S.A. | 1,720,720 | $18,360,000 | 0.37% |
Alphabet Inc. | 500,901 | $5,345,000 | 0.11% |
Casdin Capital, LLC | 216,216 | $2,307,000 | 0.06% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 84,000 | $896,000 | 0.01% |
NewSquare Capital LLC | 5,000 | $53,000 | 0.01% |
FMR LLC | 2,540,434 | $27,106,000 | 0.00% |